Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

24 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Levothyroxine Sodium Tablets Articles

Harmful drug-drug interactions for thyroid medicines identified

15 September 2008

Revised monograph for levothyroxine to be issued in USA

4 August 2008

FDA rates Lannett's levothyroxine AB

20 December 2004

KV resolves a handful of legal matters

20 September 2004

King's 2nd-qtr net loss rockets 81%

16 August 2004

King Pharma posts 36% leap in earnings

5 August 2002

Mylan Labs receives FDA approval for hyperthyroidism drug

17 June 2002

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Is the diabetes market facing a blockbuster-free future?
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Is the diabetes market facing a blockbuster-free future?
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS